No (N=41)	Yes (N=58)	P-value
Age (years)
Mean (SD)	54.9 (11.2)	55.3 (9.55)	0.333
Median [Min, Max]	53.0 [28.0, 82.0]	55.0 [24.0, 79.0]
Operation_history
Direct_surgery	32 (78.0%)	34 (58.6%)	0.0423
Septal_tumor_reduction	1 (2.4%)	0 (0%)
Surgery_after_neoadjuvant	8 (19.5%)	24 (41.4%)
Type
CCC	1 (2.4%)	1 (1.7%)	0.277
EC	2 (4.9%)	1 (1.7%)
HGSC	36 (87.8%)	53 (91.4%)
LGSC	0 (0%)	2 (3.4%)
MC	2 (4.9%)	0 (0%)
Missing	0 (0%)	1 (1.7%)
Clinical_stage
I	1 (2.4%)	0 (0%)	<0.001
II	8 (19.5%)	0 (0%)
III	24 (58.5%)	21 (36.2%)
IV	8 (19.5%)	37 (63.8%)
Planting_metastasis
No	2 (4.9%)	5 (8.6%)	0.751
Yes	39 (95.1%)	53 (91.4%)
Lymph.node_metastasis
No	41 (100%)	0 (0%)	<0.001
Yes	0 (0%)	58 (100%)
TMB_group
High	2 (4.9%)	3 (5.2%)	1
Low	39 (95.1%)	53 (91.4%)
Missing	0 (0%)	2 (3.4%)
Relapse_within_6months
Yes	4 (9.8%)	9 (15.5%)	0.524
No	26 (63.4%)	38 (65.5%)
Unknown	11 (26.8%)	11 (19.0%)